Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) for colorectal cancer screening.
Recruiting
- Conditions
- Colorectal cancer
- Registration Number
- NL-OMON20182
- Lead Sponsor
- niversity medical center, Utrecht, The NetherlandsProf. dr. Siersema, MD, PhDDepartment of Gastroenterology and HepatologyUniversity Medical Center UtrechtP.O. Box 85500, 3508 GA UtrechtHeidelberglaan 100, 3584 CX UtrechtTel.nr.: +31 88 7555555Fax.nr.: +31 88 755 5533E-mail: p.d.siersema@umcutrecht.nl
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 390
Inclusion Criteria
1. Age 50 years or older;
2. Patients who will undergo a colonoscopy because of the suspicion of having colorectal carcinoma, with at least one of the following symptoms: rectal blood loss, altered bowel habits, unexplained weight loss, abdominal pain, and/or anemia;
Exclusion Criteria
1. General contra-indications for MRI (metal devices [pacemakers, endoprotheses, intra uterine devices, neurostimulators, insulin pump, intra-ocular parts of metal, ear implants, artificial metal cardial valves], claustrophobia);
2. Weight >100kg;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Investigate whether DWIBS is effective for colorectal cancer screening.
- Secondary Outcome Measures
Name Time Method Sensitivity of DWIBS for the detection of colorectal cancer and polyps > 6mm.